SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-15-000017
Filing Date
2015-02-23
Accepted
2015-02-23 16:08:42
Documents
16
Period of Report
2015-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20150223x8xkdoc.htm 8-K 32688
2 PRESS RELEASE pdli-20150223x8xkex991.htm EX-99.1 147887
3 PRESENTATION pdli-20150223x8xkex992.htm EX-99.2 5060
4 INFORMATION SHEET pdli-20150223x8xkex993.htm EX-99.3 489476
5 pdllogo75a01a02.jpg GRAPHIC 5218
6 slide1a08.jpg GRAPHIC 133810
7 slide2a08.jpg GRAPHIC 221518
8 slide3a08.jpg GRAPHIC 92513
9 slide4a08.jpg GRAPHIC 99638
10 slide5a08.jpg GRAPHIC 139356
11 slide6a08.jpg GRAPHIC 85940
12 slide7a08.jpg GRAPHIC 128844
13 slide8a08.jpg GRAPHIC 149144
14 slide9a05.jpg GRAPHIC 106764
15 slide10.jpg GRAPHIC 140505
16 slide11.jpg GRAPHIC 116087
  Complete submission text file 0000882104-15-000017.txt   2633358
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 15639775
SIC: 2836 Biological Products, (No Diagnostic Substances)